共 50 条
- [21] CAPTOPRIL - AN ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR ACTIVE IN MAN ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1980, : 188 - 212
- [22] CONVERTING-ENZYME INHIBITOR ENALAPRIL (MK421) IN TREATMENT OF HYPERTENSION WITH RENAL-ARTERY STENOSIS BMJ-BRITISH MEDICAL JOURNAL, 1982, 285 (6356): : 1697 - 1699
- [24] ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY MK421 - A POTENT LONG-ACTING ORAL-AGENT AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (04): : 362 - 362
- [25] LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR PHARMACOTHERAPY, 1989, 9 (03): : 120 - 130
- [26] LISINOPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (05): : 365 - 372
- [28] ENALAPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR HOSPITAL FORMULARY, 1985, 20 (07): : 796 - &
- [29] INFLUENCE OF THE CONVERTING ENZYME-INHIBITOR (CEI)-MK421 AND ITS LYSINE ANALOGUE-MK521 ON BLOOD-PRESSURE (BP), PRESSOR HORMONES AND AUTONOMIC REFLEXES CLINICAL RESEARCH, 1982, 30 (01): : A26 - A26
- [30] ACUTE, SUBCHRONIC AND CHRONIC TOXICITY OF THE NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (01): : 14 - 20